|
|||||
|
|
Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score–guided treatment costs in a population-based cohort of patients with breast cancer |
|
| Authors: | Megan E Tesch MD Caroline Speers BA Rekha M Diocee BA Lovedeep Gondara MSc Stuart J Peacock MSc DPhil Alan Nichol MD Caroline A Lohrisch MD |
| Institution: | 1. Department of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada;2. Breast Cancer Outcomes Unit, BC Cancer, Vancouver, British Columbia, Canada;3. Canadian Centre for Applied Research in Cancer Control, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada;4. Department of Radiation Oncology, BC Cancer, Vancouver, British Columbia, Canada |
| Abstract: | |
| Keywords: | age factors breast cancer chemotherapy cost-benefit analysis health services needs and demands predictive genetic testing quality of health care |